Arizona 2022 2022 Regular Session

Arizona Senate Bill SB1715 Comm Sub / Analysis

Filed 02/04/2022

                    Assigned to APPROP 	FOR COMMITTEE 
 
 
 
 
ARIZONA STATE SENATE 
Fifty-Fifth Legislature, Second Regular Session 
 
FACT SHEET FOR S.B. 1715 
 
hemp-derived manufactured cannabinoids; prohibition 
Purpose 
Defines hemp-derived manufactured psychotropic cannabinoids. Contains requirements 
for enactment for initiation and referendum (Proposition 105). 
Background 
The Smart and Safe Arizona Fund (Fund) consists of monies received from tax on the sale 
of recreational marijuana products and license and registration fees. Monies in the Fund are to be 
used to pay for costs to state agencies to implement 2020 Proposition 207. The remaining monies 
are distributed as follows: 1) 33 percent to community college districts; 2) 31.4 percent to 
municipal police and fire departments; 3) 25.4 percent to the Highway User Revenue Fund; 4) 10 
percent to the Justice Reinvestment Fund; and 5) 0.2 percent to the Attorney General (A.R.S. 36-
2856). 
There is no anticipated fiscal impact to the state General Fund associated with this 
legislation. 
Provisions 
1. Defines hemp-derived manufactured psychotropic cannabinoids as any cannabinoid that is 
derived from hemp and altered by a chemical reaction that changes the molecular structure of 
any natural cannabinoid derived from hemp to another cannabinoid with psychotropic 
properties that is found naturally in hemp that includes: 
a) delta-8 tetrahydrocannabinol;  
b) delta-10 tetrahydrocannabinol; 
c) hexahydrocannabinol;  
d) tetrahydrocannabiphoral;  
e) tetrahydrocannabinol acetate ester; and  
f) tetrahydrocannabivarin. 
2. Excludes any cannabinoid derived from hemp that is produced by decarboxylation from 
naturally occurring cannabinoid acid without the use of a chemical catalyst from the definition 
hemp-derived manufactured psychotropic cannabinoids.  
3. Excludes hemp-derived manufactured psychotropic cannabinoids from the definitions of 
industrial hemp, usable marijuana, marijuana concentrate, marijuana products and 
marijuana.   FACT SHEET 
S.B. 1715 
Page 2 
 
 
4. Adds investigating and acting on the sale, marketing and distribution of hemp-derived 
manufactured psychotropic cannabinoids to the allowable uses of the Attorney General's 
portion of the Fund monies.  
5. Makes technical and conforming changes.  
6. Requires for enactment the affirmative vote of at least three-fourths of the members of each 
house of the Legislature (Proposition 105).  
7. Becomes effective on the general effective date.  
Prepared by Senate Research 
February 4, 2022 
LMM/sr